HomeGeneticsConditionUsher syndrome
Back to Condition
Usher syndrome
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Condition

Usher syndrome

Usher syndrome is a genetic condition characterized by a combination of hearing loss and progressive vision loss caused by retinitis pigmentosa.

Overview

Usher syndrome involves sensorineural hearing loss and vision loss due to retinitis pigmentosa (RP), a disease that causes the light-sensitive cells of the retina to break down. Vision loss typically begins with night blindness, followed by the development of blind spots that eventually lead to tunnel vision.

Types of Usher Syndrome

  • Type I: Characterized by severe to profound hearing loss from birth, childhood-onset vision loss, and vestibular (balance) abnormalities.
  • Type II: Involves hearing loss from birth (ranging from mild to severe) and progressive vision loss beginning in adolescence or adulthood. It is not associated with balance problems.
  • Type III: Features normal hearing at birth, with hearing and vision loss developing in late childhood or adolescence. Balance problems may occur in some individuals.

Causes

Usher syndrome is caused by mutations in several different genes, including MYO7A, CDH23, USH2A, and CLRN1. These genes provide instructions for proteins essential to the development and function of hair cells in the inner ear (for hearing and balance) and photoreceptor cells in the retina (for vision). Mutations lead to the degeneration of these sensory cells.

Inheritance

All types of Usher syndrome are inherited in an autosomal recessive pattern. This means that both copies of the gene in each cell must have a mutation for the condition to occur. Parents of an affected individual are carriers, each possessing one mutated copy of the gene, but they do not show signs or symptoms of the syndrome.

Frequently Asked Questions

Night blindness, difficulty seeing in low light, or the appearance of dark spots in the visual field are early warning signs. A pediatric ophthalmologist should perform a dilated retinal exam within 6–12 months of first symptoms to assess retinitis pigmentosa progression.
Type I usually presents with profound hearing loss from birth and may benefit from early cochlear implantation. Type II has milder, progressive loss; hearing aids and speech‑language therapy are common. Type III may show late‑onset loss; monitoring and timely device fitting are key. Regular audiology assessments guide device adjustments.
Research is underway for gene replacement and gene editing therapies targeting USH2A and other genes. Families should consult a geneticist or research center to learn about eligibility for ongoing trials, which may offer future treatment options.
Screen readers, voice‑activated assistants, and large‑print or Braille materials aid vision. For hearing, captioned videos, real‑time transcription, and hearing‑aided devices help. Community resources such as orientation and mobility training, support groups, and vocational counseling provide additional assistance.===
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

Meyahealth

Ⓒ 2026. All rights reserved by MEYA